Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationMultiple MyelomaMelphalanTransplantation, HomologousTransplantation ConditioningTreatment OutcomeCyclophosphamideDisease-Free SurvivalRemission InductionSalvage TherapyEtoposideHodgkin DiseaseStem CellsSurvival RateLymphoma, Non-HodgkinVincristineCytarabineHematopoietic Stem Cell MobilizationRecurrenceSurvival AnalysisMyeloablative AgonistsCarmustineDoxorubicinBone Marrow TransplantationThiotepaGraft vs Host DiseaseBone Marrow PurgingPrognosisHematologic NeoplasmsAntineoplastic AgentsChemotherapy, AdjuvantRetrospective StudiesWhole-Body IrradiationLymphoma, Mantle-CellAntibodies, Monoclonal, Murine-DerivedFollow-Up StudiesAmyloidosisBusulfanHematopoietic Stem CellsDexamethasoneBoronic AcidsAntineoplastic Agents, AlkylatingCisplatinPyrazinesGranulocyte Colony-Stimulating FactorGraft SurvivalPrednisoneIfosfamideLymphoma, FollicularAntigens, CD34Induction ChemotherapyAutograftsTime FactorsLymphoma, T-Cell, PeripheralThalidomideLiver TransplantationLymphoma, Large B-Cell, DiffuseLymphomaLeukapheresisMesenchymal Stem Cell TransplantationCarboplatinPodophyllotoxinNeoplasm, ResidualMaintenance ChemotherapyLeukemia, Myeloid, AcuteNeoplasm Recurrence, LocalTransplantation ChimeraProspective StudiesDrug Administration ScheduleNeoplasm StagingAntibodies, MonoclonalTissue DonorsCell TransplantationMitoxantroneCord Blood Stem Cell TransplantationBreast NeoplasmsLymphoma, B-CellIdarubicinMyelodysplastic SyndromesNeoplasms, Second PrimaryKidney TransplantationBlood Transfusion, AutologousBleomycinEnteropathy-Associated T-Cell LymphomaEmbryonic Stem CellsLeukemia, Plasma CellBlood Component RemovalMethotrexateInfusions, SpinalFeasibility StudiesImmunosuppressive AgentsNeutropeniaAdult Stem CellsKaplan-Meier EstimateClinical Trials as Topic